$IMAX

IMAX MELBOURNE ONLY CINEMA IN SOUTHERN HEMISPHERE TO SCREEN NOLAN’S THE ODYSSEY ON IMAX 70MM FILM

IMAX Melbourne is the only cinema in the Southern Hemisphere to screen Christopher Nolan's THE ODYSSEY on IMAX 70mm Film. The theatre sold 17,000 tickets and $800,000 in box office revenue in under 24 hours. IMAX Melbourne is one of IMAX Corp's top 8 performing cinemas globally, with THE ODYSSEY expected to drive further demand.

Original reporting
Published Sep 24, 2026, 1:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 4:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IMAX MELBOURNE ONLY CINEMA IN SOUTHERN HEMISPHERE TO SCREEN NOLAN’S THE ODYSSEY ON IMAX 70MM FILM — source image
Decision brief

The 30-second read

$IMAXBullishLow
01

Why it matters

The event showcases demand for premium cinema formats, offering a data point for IMAX Corp.'s growth strategy.

02

Market read

First‑time 70mm screening drives strong local sales, indicating potential upside for IMAX's premium format segment.

03

What to watch

Potential supply constraints for 70mm prints could limit further roll‑outs.

Relevance 4/10Novelty 5/10Timing: pre‑release hype for July 16 opening

Background

The article reports the inaugural IMAX 70mm screening of Christopher Nolan's THE ODYSSEY in Melbourne, noting record ticket sales and revenue.

Company-level read

Ticker impact

$IMAXBullishMedium confidence
Context

IMAX Melbourne sold >17,000 tickets and $800,000 gross in 24 hours for the Nolan film, a first‑time IMAX 70mm showing in the Southern Hemisphere.

Expected impact

Modest upside potential if the trend scales to other locations.

Evidence & confidence

The sales figures are new and sizable for a single venue, but overall impact on the global company is limited.

Market effects

Highlights growing consumer appetite for premium large‑format cinema experiences.

Boosts Australian entertainment venue outlook.

May encourage IMAX to expand 70mm offerings worldwide.

Counterpoint

One venue's surge may not translate to broader earnings growth for IMAX Corp.

Key entities

  • IMAX Corp.

    Operator of IMAX theatres worldwide, ticker IMAX.

  • Christopher Nolan

    Director of THE ODYSSEY.

Related articles

$IMAXHigh

Imax is a must for movie theaters, making the stock a buy, Morgan Stanley says

Morgan Stanley initiated coverage of Imax with an overweight rating and a $63 price target, suggesting 18% upside. The bank cites Imax's growing network, film slate, and box office revenue growth. Imax's box office is projected to reach $1.7 billion in 2028, up from $1.5 billion in 2026. The success of 'The Odyssey' highlights the value of Imax's technology and brand. 12 of 14 analysts rate Imax a buy or strong buy, and shares are up 21% over the past three months.

$AMCHighAI 8/10

AMC Spikes 7% as Refinancing Pushes Maturities From 2029 to 2031; Cinemark and IMAX Edge Higher

AMC Entertainment (AMC) shares rose 7% to $2.88 after announcing debt refinancing, pushing its nearest large maturity from 2029 to 2031. The move involves a private placement of first lien notes due 2031 and a cash tender offer for outstanding 2029 notes, funded by new debt facilities. Cinemark (CNK) and IMAX (IMAX) stocks also rose, but less significantly. AMC's refinancing aims to simplify its debt structure and extend maturities, though it does not reduce the total debt.

$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.